The economic impact of anastomotic leak after colorectal cancer surgery.

Autors de IIS La Fe
Autors aliens a IIS La Fe
- Noguera-Aguilar, Jose Francisco
- Delgado-Rivilla, Salvadora
- Garcia-Gonzalez, Jose Maria
- Rodriguez-Martin, Marcos
- Salinas-Ortega, Laura
- Casado, Miguel Angel
- Alvarez, Maria
Grups d'Investigació
Abstract
OBJECTIVE: To determine the economic impact of the incremental consumption of resources for the diagnosis and treatment of anastomotic leak (AL) in patients after resection with anastomosis for colorectal cancer compared to patients without AL on the Spanish health system. METHOD: This study included a literature review with parameters validated by experts and the development of a cost analysis model to estimate the incremental resource consumption of patients with AL versus those without. The patients were divided into three groups: 1) colon cancer (CC) with resection, anastomosis and AL; 2) rectal cancer (RC) with resection, anastomosis without protective stoma and AL; and 3) RC with resection, anastomosis with protective stoma and AL. RESULTS: The average total incremental cost per patient was €38,819 and €32,599 for CC and RC, respectively. The cost of AL diagnosis per patient was €1018 (CC) and €1030 (RC). The cost of AL treatment per patient in Group 1 ranged from €13,753 (type B) to €44,985 (type C + stoma), that in Group 2 ranged from €7348 (type A) to €44,398 (type C + stoma), and that in Group 3 ranged from €6197 (type A) to €34,414 (type C). Hospital stays represented the highest cost for all groups. In RC, protective stoma was found to minimize the economic consequences of AL. CONCLUSIONS: The appearance of AL generates a considerable increase in the consumption of health resources, mainly due to an increase in hospital stays. The more complex the AL, the higher the cost associated with its treatment. INTEREST OF THE STUDY: it is the first cost-analysis study of AL after CR surgery based on prospective, observational and multicenter studies, with a clear, accepted and uniform definition of AL and estimated over a period of 30 days.
© 2023. The Author(s).
Dades de la publicació
- ISSN/ISSNe:
- 2191-1991, 2191-1991
- Tipus:
- Article
- Pàgines:
- 12-12
- PubMed:
- 36795234
- Factor d'Impacte:
- 0,535 SCImago ℠
- Quartil:
- Q2 SCImago ℠
Health Economics Review Springer Science and Business Media Deutschland GmbH
Documents
- No hi ha documents
Filiacions
Keywords
- Anastomotic leak; Colorectal cancer; Cost; Resection; Spain; Stoma
Projectes associats
Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.
Investigador Principal: BLAS FLOR LORENTE
PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018
"TIMing Evaluation of Stoma closure” Cierre precoz vs tardío del estoma derivativo tras cirugía de cáncer de recto.
Investigador Principal: MATTEO FRASSON
2018_0078_CRC_FRASSON . ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA (AECP) . 2018
Trocar multisensor para cirugía laparoscópica con presión de pneumoperitoneo individualizada
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
INNVAL10/18/056 . AGENCIA VALENCIANA DE LA INNOVACION (AVI) . 2018
INDIVIDUALIZED PERIOPERATIVE HEMODYNAMIC GOAL-DIRECTED THERAPY IN MAJOR ABDOMINAL SURGERY (IPEGASUS-TRIAL).
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPEGASUS . 2017
MU OPIOID RECEPTOR 1 (MOR-1) EXPRESSION IN COLORECTAL CANCER AND DISEASE-FREE SURVIVAL RELATIONSHIP (MOROCCO). FIVE-YEAR FOLLOW-UP.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
ODC-MOR-2018-01
PRESIÓN INDIVIDUALIZADA DE INSUFLACIÓN DEL PNEUMOPERITONEO EN CIRUGÍA LAPAROSCÓPICA COLORECTAL FRENTE A TERAPIA ESTÁNDAR.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPPCOLLAPSE-II . 2016
Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal snapshot An international, multi-centre study of emergency presentations of colorectal cancer.
Investigador Principal: JORGE SANCHO MURIEL
APOLLO . 2023
HEMO-FISSQoL - Traducción validada al español de un instrumento de medida de la calidad de vida en pacientes con patología hemorroidal y fisura anal.
Investigador Principal: HANNA BARBARA CHOLEWA
HEMO-FISSQoL . 2023